Effect of long-term vigabatrin therapy on GABA and other amino acid concentrations in the central nervous system--a case study.
A 32 year old patient with refractory complex partial seizures was treated with vigabatrin for 3.5 years. Before starting treatment and at 42 months, lumbar punctures were done and the CSF analyzed for amino acids including GABA. Although the patient experienced a 50% seizure reduction, he underwent a left sided temporal lobectomy, and the tissue sample was also analyzed for amino acid content. It was found that vigabatrin caused a three-fold increase in total and free GABA in both the tissue sample and CSF. There were no other significant changes in the other amino acids analyzed. Seizure reduction seen initially was maintained over the long-term observation period. The finding of a specific increase of GABA in brain tissue and CSF of this patient treated with vigabatrin provides additional support to the concept that the primary effect of vigabatrin is as a selective enzyme activated irreversible inhibitor of GABA transaminase.
Ben-Menachem
E
E
Department of Neurology, University of Göteborg, Sweden.
Hamberger
A
A
Mumford
J
J
D000328:Adult; D000596:Amino Acids / Q000134:cerebrospinal fluid / Q000378:metabolism*; D000614:Aminocaproates / Q000008:administration & dosage*; D000927:Anticonvulsants / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D013702:Temporal Lobe / Q000187:drug effects* / Q000378:metabolism; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000134:cerebrospinal fluid / Q000378:metabolism*
D000596:Amino Acids; D000614:Aminocaproates; D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D020888:Vigabatrin